But TB-500 as sold in grey markets is not the same thing as a well-characterized pharmaceutical product, and the FDAs Category 2 listing includes Thymosin Beta-4, Fragment (LKKTETQ) as a substance raising significant safety risks in compounding contexts
GI Research Evidence Ulcerative colitis
nausea at elevated doses (anecdotal, human) injection site discomfort (anecdotal) Where to source Research use only Affiliate link we may earn a commission at no extra cost to you
Well Reach Out Within 24 Business Hours Our team will contact you to send intake forms, provide access to our patient portal, and schedule your appointment
Limitation of Liability To the fullest extent permitted by law, BGX and its owners, officers, employees, contractors, suppliers, and agents will not be liable for indirect, incidental, special, exemplary, punitive, or consequential damages